Main navigation
Search Results
-
-
Dossier - 20/01/2014 Optogenetics switching cell activity on and off with light
What still sounds like science fiction to the general public has long been within reach for many years scientists have been able to manipulate neural activity selectively with light. They use different wavelengths to turn cells on and off as if they were a standard switch. Optogenetics is an emerging technology that combines optics and genetics. The technology is already used in many different ways for many different purposes by numerous research…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/optogenetics-switching-cell-activity-on-and-off-with-light -
Dossier - 16/12/2013 Microbial raw material recycling
While the use of biotechnological methods for the purification of water, soil and air has already been state of the art for quite a few years, the use of microorganisms for the recovery of metal and mineral raw materials from industrial and agricultural waste has also started to attract the interest of scientists. This dossier addresses this topic, explains what geobiotechnology and urban mining are all about.
https://www.biooekonomie-bw.de/en/articles/dossiers/microbial-raw-material-recycling -
Dossier - 09/12/2013 Industrial biotechnology biological resources for industrial processes
Industrial or white biotechnology uses microorganisms and enzymes to produce goods for industry, including chemicals, plastics, food, agricultural and pharmaceutical products and energy carriers. Renewable raw materials and increasingly also waste from agriculture and forestry are used for the manufacture of industrial goods.
https://www.biooekonomie-bw.de/en/articles/dossiers/industrial-biotechnology-biological-resources-for-industrial-processes -
Dossier - 02/12/2013 RNA interference confidence is returning
The 15-year history of RNA interference is not short on dramatic effects. It begins with the unexpected discovery and publication of the process of post-transcriptional gene silencing in 1998 for which the two Americans Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine just eight years after their discovery. In 2001 Thomas Tuschl succeeded in switching off genes in human cells with small synthetic pieces of RNA…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/rna-interference-confidence-is-returning -
-
-
-
Dossier - 15/10/2013 Adult stem cells hope for regenerative therapies
Adult stem cells have the lifelong ability to generate new specialised cells. They secure the continuous replenishment of cells therefore enabling the constant replacement of dying cells with new ones. Progress in the characterisation isolation and specific differentiation of adult stem cells over recent years raises hopes for the future use of the cells in the therapy of degenerative diseases. Knowledge about adult stem cells also has the…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/adult-stem-cells-hope-for-regenerative-therapies -
Dossier - 23/09/2013 Bioeconomy a new model for industry and the economy
On the one hand, a bioeconomy relies on renewable resources to meet society’s need for food, energy and industrial products. On the other, it emphasises the role of biogenic material flows. The bioeconomy model is expected to reduce our dependency on fossil fuels in the long term. In order to implement the shift to a biobased economy on the regional level, the Baden-Württemberg government launched the Bioeconomy Research Strategy in summer 2013.
https://www.biooekonomie-bw.de/en/articles/dossiers/bioeconomy-a-new-model-for-industry-and-the-economy -
-
-
-
Dossier - 08/07/2013 Biodiversity in crisis
Biodiversity is essential for functioning, stable ecosystems and the wellbeing of the human race. Despite conventions, resolutions and action plans for the protection of biological diversity at all political levels, the decline of species diversity is increasing dramatically all over the world, including Germany. Targeted projects and funding measures have been put in place with the objective of stopping this deadly trend.
https://www.biooekonomie-bw.de/en/articles/dossiers/biodiversity-in-crisis -
-
-
Dossier - 21/05/2013 No new drugs to be placed on the market without clinical trials
New pharmaceuticals are subject to approval by drug authorities. Prior to approval of a new pharmaceutical several hurdles such as preclinical and clinical studies need to be cleared. Clinical trials are performed to ensure the quality efficacy and safety of a medicinal product. Clinical development is a time-consuming and costly process and takes on average ten to fifteen years before a pharmaceutical company can apply for the approval of the…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/no-new-drugs-to-be-placed-on-the-market-without-clinical-trials -
-
Dossier - 15/04/2013 Bioactive plant foods more than just filling
The increasing demand for functional foods clearly shows that the role of food is no longer just to meet an essential need. Food that offers additional nutritional benefits is becoming increasingly important for example food that is able to prevent or treat diseases. This kind of food is therefore interesting for consumers the food industry and the healthcare sector alike. Products based on plant raw materials are particularly in demand due to…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/bioactive-plant-foods-more-than-just-filling -
Dossier - 01/04/2013 Retroviruses from infectious agent to therapeutic assistant
Viruses are infectious particles that use the machinery and metabolism of a host cell to replicate. Despite some similarities with accepted forms of life viruses are not considered as such. The family of retroviruses is particularly known for its most notorious representative i. e. the human immunodeficiency virus HIV which leads to AIDS and for which no cure or effective vaccine is currently available. However retroviruses are not only of…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/retroviruses-from-infectious-agent-to-therapeutic-assistant -
Dossier - 25/03/2013 Biotechnology goes automated
Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-goes-automated -
Dossier - 25/03/2013 Biotechnology goes automated
Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences.
https://www.biooekonomie-bw.de/en/articles/dossiers/biotechnology-goes-automated -
Dossier - 20/12/2012 Medical technology serving healthcare
Modern healthcare would be impossible without medical technology. The achievements in medical technology are indispensable for our health and quality of life. The range of medical technology available covers surgical instruments and implants to diagnostic methods and medical devices.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/medical-technology-serving-healthcare -
Dossier - 26/11/2012 Genetic diagnostics technology reaches the limits of what is medically reasonable
Rapid progress in sequencing technologies is poised to set the imagination of biomedical researchers on fire. Experts now believe that progress is about to make possible what seemed to be utopian a few years ago – it seems likely that it will soon be possible to sequence the human genome in only a few minutes and store and automatically analyse it using tiny automates. However, is everything that is technically feasible also reasonable?
https://www.gesundheitsindustrie-bw.de/en/article/dossier/genetic-diagnostics-technology-reaches-the-limits-of-what-is-medically-reasonable -
Dossier - 05/11/2012 Cancer basic research successes and trends
Science is approaching cancer treatment by using new systems biology approaches and setting up large-scale multidisciplinary projects such as the International Cancer Genome Consortium. Progress in genome, epigenome and gene expression analyses of cancer cells, new insights into the regulation and interaction of cells gained in cooperation with stem cell research and virus research contributes to gaining a causal understanding of cancer.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/cancer-basic-research-successes-and-trends